5 Stocks Still Offering Stunning Value

Leverage Your Profits With
“The Survivors”

The bear market has mauled many stocks so badly that investors have given them up for dead. And that’s the source of a
huge opportunity.

Some of those wounded and bleeding companies are destined to survive — and heal. And a select few will double, triple
and even quadruple over the next two or three years.

I’m not saying these “survivor stocks” are for everyone. There’s a risk that some of them will run into financial
or operational barriers that prevent a recovery — you could still lose most or all of your investment.

Nonetheless, I’m convinced the odds of an economic rebound have improved enough to make it worth betting on a handful
of turnaround stories. As long as you carefully limit your exposure (no more than 1% of your portfolio in each stock, and no more
than 5% in the whole package), you may find that the rewards outweigh the risks by a wide margin.

Here are five of my favorite turnaround candidates…

NEXT: Stock #1: Abbott Laboratories (ABT)